Northern Trust Corp Infinity Pharmaceuticals, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.16 - $0.74 $145 - $673	-910 Reduced 0.54%	168,040 $26,000
Q3 2022 Nov 14, 2022	BUY	$0.59 - $1.7 $336 - $969	570 Added 0.34%	168,950 $201,000
Q2 2022 Aug 12, 2022	SELL	$0.49 - $1.2 $298,804 - $731,766	-609,805 Reduced 78.36%	168,380 $106,000
Q1 2022 May 13, 2022	SELL	$0.85 - $2.4 $30,069 - $84,902	-35,376 Reduced 4.35%	778,185 $887,000
Q4 2021 Feb 08, 2022	SELL	$1.86 - $3.36 $223,155 - $403,119	-119,976 Reduced 12.85%	813,561 $1.83 Million
Q3 2021 Nov 15, 2021	SELL	$1.52 - $3.82 $73,069 - $183,635	-48,072 Reduced 4.9%	933,537 $3.19 Million
Q2 2021 Aug 13, 2021	BUY	$2.66 - $3.47 $2.05 Million - $2.67 Million	769,207 Added 362.15%	981,609 $2.94 Million
Q1 2021 May 12, 2021	BUY	$1.98 - $5.36 $106,680 - $288,791	53,879 Added 33.99%	212,402 $686,000
Q4 2020 Feb 11, 2021	SELL	$1.05 - $2.77 $8,230 - $21,714	-7,839 Reduced 4.71%	158,523 $336,000
Q3 2020 Nov 16, 2020	SELL	$0.82 - $1.34 $1,593 - $2,603	-1,943 Reduced 1.15%	166,362 $195,000
Q2 2020 Aug 14, 2020	SELL	$0.77 - $1.13 $4,310 - $6,325	-5,598 Reduced 3.22%	168,305 $152,000
Q1 2020 May 14, 2020	SELL	$0.69 - $1.52 $231 - $509	-335 Reduced 0.19%	173,903 $146,000
Q4 2019 Feb 14, 2020	SELL	$0.88 - $1.29 $1,054 - $1,545	-1,198 Reduced 0.68%	174,238 $167,000
Q3 2019 Nov 13, 2019	SELL	$1.03 - $1.75 $759 - $1,289	-737 Reduced 0.42%	175,436 $181,000
Q2 2019 Aug 13, 2019	BUY	$1.43 - $1.87 $9,046 - $11,829	6,326 Added 3.72%	176,173 $317,000
Q1 2019 May 13, 2019	SELL	$1.18 - $1.91 $139 - $225	-118 Reduced 0.07%	169,847 $320,000
Q4 2018 Feb 12, 2019	SELL	$1.01 - $2.78 $4,132 - $11,375	-4,092 Reduced 2.35%	169,965 $201,000
Q3 2018 Nov 14, 2018	SELL	$1.72 - $2.71 $5,395 - $8,501	-3,137 Reduced 1.77%	174,057 $472,000
Q2 2018 Sep 18, 2018	SELL	$1.72 - $2.26 $2,146 - $2,820	-1,248 Reduced 0.7%	177,194 $339,000
Q2 2018 Aug 14, 2018	BUY	$1.72 - $2.26 $17,977 - $23,621	10,452 Added 6.22%	178,442 $342,000
Q1 2018 May 09, 2018	BUY	$1.8 - $2.74 $5,945 - $9,050	3,303 Added 2.01%	167,990 $353,000
Q4 2017 Feb 14, 2018	SELL	$1.22 - $3.73 $262,002 - $801,039	-214,756 Reduced 56.6%	164,687 $334,000
Q3 2017 Nov 13, 2017	BUY	$0.94 - $1.35 $356,676 - $512,248	379,443	379,443 $505,000

Others Institutions Holding INFI

# of Institutions

Shares Held

1.26M

Call Options Held

Put Options Held

View Full List

About INFINITY PHARMACEUTICALS, INC.

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

More about INFI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account